Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M – Xconomy
Xconomy |
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M
Xconomy Xconomy Boston —. The founders of CRISPR-Cas9 startup Editas Medicine have gotten a jump on the next version of CRISPR gene editing. Scientists from Harvard University, Massachusetts General Hospital, and the Broad Institute are behind Beam … Feng Zhang's base-editing CRISPR startup officially launches with $87M A pencil, not a pair of scissors: CRISPR pioneers' new company bets on base editing to cure disease CRISPR trailblazers Zhang, Liu and Joung join forces to launch Beam with $87M and cutting-edge gene-editing tech |
